chr21-46161623-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001142854.2(SPATC1L):c.779G>T(p.Arg260Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000046 in 1,610,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000028 ( 0 hom. )
Consequence
SPATC1L
NM_001142854.2 missense
NM_001142854.2 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 0.815
Genes affected
SPATC1L (HGNC:1298): (spermatogenesis and centriole associated 1 like) Enables identical protein binding activity. Predicted to act upstream of or within several processes, including actin polymerization or depolymerization; positive regulation of cAMP-dependent protein kinase activity; and positive regulation of protein kinase A signaling. Predicted to be located in sperm connecting piece. Predicted to be active in centrosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0714933).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATC1L | NM_001142854.2 | c.779G>T | p.Arg260Leu | missense_variant | 5/5 | ENST00000291672.6 | NP_001136326.1 | |
SPATC1L | NM_032261.5 | c.317G>T | p.Arg106Leu | missense_variant | 4/4 | NP_115637.3 | ||
SPATC1L | XM_005261188.6 | c.779G>T | p.Arg260Leu | missense_variant | 5/5 | XP_005261245.1 | ||
SPATC1L | XM_011529756.3 | c.437G>T | p.Arg146Leu | missense_variant | 3/3 | XP_011528058.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATC1L | ENST00000291672.6 | c.779G>T | p.Arg260Leu | missense_variant | 5/5 | 2 | NM_001142854.2 | ENSP00000291672.5 | ||
SPATC1L | ENST00000330205.10 | c.317G>T | p.Arg106Leu | missense_variant | 4/4 | 1 | ENSP00000333869.6 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152042Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
33
AN:
152042
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000420 AC: 10AN: 237828Hom.: 0 AF XY: 0.0000230 AC XY: 3AN XY: 130328
GnomAD3 exomes
AF:
AC:
10
AN:
237828
Hom.:
AF XY:
AC XY:
3
AN XY:
130328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1458154Hom.: 0 Cov.: 32 AF XY: 0.0000221 AC XY: 16AN XY: 725242
GnomAD4 exome
AF:
AC:
41
AN:
1458154
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
725242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000217 AC: 33AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74406
GnomAD4 genome
AF:
AC:
33
AN:
152160
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.779G>T (p.R260L) alteration is located in exon 5 (coding exon 4) of the SPATC1L gene. This alteration results from a G to T substitution at nucleotide position 779, causing the arginine (R) at amino acid position 260 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
0.87
.;P
Vest4
MVP
MPC
0.36
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at